Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
Journalists
Submit Release
January 24, 2009
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Websites.
 
Close Move
All Press Releases for September 4, 2008 Subscribe to this News Feed    
 

NIH Awards First EUREKA Grants for Exceptionally Innovative Research

The National Institutes of Health (NIH) has awarded Todd Lencz, PhD, a EUREKA grant designed to help investigators test novel ideas.

The National Institutes of Health (NIH) has awarded Todd Lencz, PhD, a EUREKA grant designed to help investigators test novel ideas. NIH awarded 38 such awards today, for a total of $42.2 million in research funds. EUREKA stands for Exceptional, Unconventional Research Enabling Knowledge Acceleration. These grants are the first offered through this innovative program.

North Shore-LIJ Health System Logo
North Shore-LIJ Health System Logo

Dr. Lencz directs the Laboratory of Analytical Genomics at the Zucker Hillside Hospital and at The Feinstein Institute for Medical Research. The discovery of genes linked to severe mental illnesses is helping scientists understand what causes a person to think or behave in abnormal ways and Dr. Lencz is leading the way in this effort, conducting a large-scale genome-wide scan to identify molecular subtypes of schizophrenia. For 100 years, psychiatry has used virtually the same set of criteria for diagnosing mental illness, which rely on the subjective reports of patients. The goal of Dr. Lencz' research is to utilize 21st century genetic technology to develop more objective tools to characterize mental disorders. Eventually, such tools may be used to more accurately predict, treat, and prevent serious mental illnesses.

"EUREKA projects promise remarkable outcomes that could revolutionize science," said NIH Director Elias A. Zerhouni, M.D. "The program reflects NIH's commitment to supporting potentially transformative research, even if it carries a greater than usual degree of scientific risk."
Dr. Lencz will receive a total of nearly a million dollars to pursue his innovative research. The EUREKA grant was funded through the National Institute of Mental Health.

Zucker Hillside Hospital scientists, members of The Feinstein Institute for Medical Research, have led the way in research on schizophrenia for more than two decades. The hospital has played a major role in establishing the best treatment approaches for the initial phases of this illness and beyond.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/RW1wdC1NYWduLUxvdmUtTG92ZS1QaWdnLVNpbmctWmVybw==

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Terry Lynam
North Shore Long Island Jewish Health System
516-562-1232
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2009, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright